(FCX) Freeport-McMoran Copper - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US35671D8570
Stock: Copper, Gold, Molybdenum, Silver
Total Rating 57
Risk 61
Buy Signal -0.96
| Risk 5d forecast | |
|---|---|
| Volatility | 50.1% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.11 |
| Alpha | 35.15 |
| Character TTM | |
|---|---|
| Beta | 1.469 |
| Beta Downside | 1.996 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.34% |
| CAGR/Max DD | 0.39 |
EPS (Earnings per Share)
Revenue
Description: FCX Freeport-McMoran Copper March 04, 2026
Freeport-McMoRan Inc. (FCX) is a US-based mining company. It operates globally, with significant assets in North America, South America, and Indonesia.
The company primarily extracts copper, gold, and molybdenum. Copper is a key industrial metal, widely used in construction and electronics. Mining operations are capital-intensive and subject to commodity price fluctuations.
Key operational sites include the Grasberg district in Indonesia and several mines across Arizona, New Mexico, Colorado, Peru, and Chile. These locations represent a diversified portfolio of mineral resources.
For more detailed financial analysis and performance metrics, consider exploring ValueRays comprehensive data.
Headlines to watch out for
- Global copper prices dictate revenue and profitability
- Indonesian mining regulations impact production and costs
- Gold price fluctuations influence overall earnings
- Energy costs affect mining and processing expenses
- Labor relations and strikes disrupt operations
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 5.36 > 1.0 |
| NWC/Revenue: 30.19% < 20% (prev 31.03%; Δ -0.84% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.61b > Net Income 2.20b |
| Net Debt (8.15b) to EBITDA (8.76b): 0.93 < 3 |
| Current Ratio: 2.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.44b) vs 12m ago -0.14% < -2% |
| Gross Margin: 26.98% > 18% (prev 0.29%; Δ 2669 % > 0.5%) |
| Asset Turnover: 45.55% > 50% (prev 45.84%; Δ -0.28% > 0%) |
| Interest Coverage Ratio: 17.65 > 6 (EBITDA TTM 8.76b / Interest Expense TTM 369.0m) |
Altman Z'' 1.78
| A: 0.13 (Total Current Assets 13.79b - Total Current Liabilities 6.02b) / Total Assets 58.17b |
| B: 0.02 (Retained Earnings 1.39b / Total Assets 58.17b) |
| C: 0.12 (EBIT TTM 6.51b / Avg Total Assets 56.51b) |
| D: 0.05 (Book Value of Equity 1.24b / Total Liabilities 27.40b) |
| Altman-Z'' Score: 1.78 = BBB |
Beneish M -2.58
| DSRI: 1.44 (Receivables 1.68b/1.14b, Revenue 25.74b/25.14b) |
| GMI: 1.06 (GM 26.98% / 28.59%) |
| AQI: 1.13 (AQ_t 0.06 / AQ_t-1 0.06) |
| SGI: 1.02 (Revenue 25.74b / 25.14b) |
| TATA: -0.06 (NI 2.20b - CFO 5.61b) / TA 58.17b) |
| Beneish M-Score: -2.58 (Cap -4..+1) = A |
What is the price of FCX shares?
As of March 09, 2026, the stock is trading at USD 59.36 with a total of 25,906,317 shares traded.
Over the past week, the price has changed by -13.08%, over one month by -6.68%, over three months by +32.24% and over the past year by +74.45%.
Over the past week, the price has changed by -13.08%, over one month by -6.68%, over three months by +32.24% and over the past year by +74.45%.
Is FCX a buy, sell or hold?
Freeport-McMoran Copper has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy FCX.
- StrongBuy: 8
- Buy: 5
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FCX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.5 | 12% |
| Analysts Target Price | 66.5 | 12% |
FCX Fundamental Data Overview March 07, 2026
P/E Trailing = 39.0526
P/E Forward = 25.0
P/S = 3.292
P/B = 4.7651
P/EG = 4.0369
Revenue TTM = 25.74b USD
EBIT TTM = 6.51b USD
EBITDA TTM = 8.76b USD
Long Term Debt = 9.92b USD (from longTermDebt, last quarter)
Short Term Debt = 569.0m USD (from shortTermDebt, last quarter)
Debt = 11.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.15b USD (from netDebt column, last quarter)
Enterprise Value = 92.99b USD (85.31b + Debt 11.50b - CCE 3.82b)
Interest Coverage Ratio = 17.65 (Ebit TTM 6.51b / Interest Expense TTM 369.0m)
EV/FCF = 16.58x (Enterprise Value 92.99b / FCF TTM 5.61b)
FCF Yield = 6.03% (FCF TTM 5.61b / Enterprise Value 92.99b)
FCF Margin = 21.79% (FCF TTM 5.61b / Revenue TTM 25.74b)
Net Margin = 8.54% (Net Income TTM 2.20b / Revenue TTM 25.74b)
Gross Margin = 26.98% ((Revenue TTM 25.74b - Cost of Revenue TTM 18.80b) / Revenue TTM)
Gross Margin QoQ = 18.05% (prev 29.93%)
Tobins Q-Ratio = 1.60 (Enterprise Value 92.99b / Total Assets 58.17b)
Interest Expense / Debt = 0.96% (Interest Expense 110.0m / Debt 11.50b)
Taxrate = 26.37% (202.0m / 766.0m)
NOPAT = 4.80b (EBIT 6.51b * (1 - 26.37%))
Current Ratio = 2.29 (Total Current Assets 13.79b / Total Current Liabilities 6.02b)
Debt / Equity = 0.61 (Debt 11.50b / totalStockholderEquity, last quarter 18.90b)
Debt / EBITDA = 0.93 (Net Debt 8.15b / EBITDA 8.76b)
Debt / FCF = 1.45 (Net Debt 8.15b / FCF TTM 5.61b)
Total Stockholder Equity = 18.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 2.20b / Total Assets 58.17b)
RoE = 11.97% (Net Income TTM 2.20b / Total Stockholder Equity 18.37b)
RoCE = 23.02% (EBIT 6.51b / Capital Employed (Equity 18.37b + L.T.Debt 9.92b))
RoIC = 17.31% (NOPAT 4.80b / Invested Capital 27.70b)
WACC = 10.07% (E(85.31b)/V(96.81b) * Re(11.33%) + D(11.50b)/V(96.81b) * Rd(0.96%) * (1-Tc(0.26)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF] Terminal Value 74.85% ; FCFF base≈4.31b ; Y1≈5.31b ; Y5≈9.05b
[DCF] Fair Price = 69.08 (EV 107.43b - Net Debt 8.15b = Equity 99.28b / Shares 1.44b; r=10.07% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -44.58 | EPS CAGR: -30.06% | SUE: -0.82 | # QB: 0
Revenue Correlation: 38.24 | Revenue CAGR: -3.21% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.090 | Chg30d=+0.100 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=+0.208 | Chg30d=+0.354 | Revisions Net=+6 | Growth EPS=+69.1% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=3.58 | Chg7d=+0.091 | Chg30d=+0.275 | Revisions Net=+5 | Growth EPS=+19.5% | Growth Revenue=+16.5%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.8% (Discount Rate 11.3% - Earnings Yield 2.6%)
[Growth] Growth Spread = -22.3% (Analyst -13.5% - Implied 8.8%)
P/E Forward = 25.0
P/S = 3.292
P/B = 4.7651
P/EG = 4.0369
Revenue TTM = 25.74b USD
EBIT TTM = 6.51b USD
EBITDA TTM = 8.76b USD
Long Term Debt = 9.92b USD (from longTermDebt, last quarter)
Short Term Debt = 569.0m USD (from shortTermDebt, last quarter)
Debt = 11.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.15b USD (from netDebt column, last quarter)
Enterprise Value = 92.99b USD (85.31b + Debt 11.50b - CCE 3.82b)
Interest Coverage Ratio = 17.65 (Ebit TTM 6.51b / Interest Expense TTM 369.0m)
EV/FCF = 16.58x (Enterprise Value 92.99b / FCF TTM 5.61b)
FCF Yield = 6.03% (FCF TTM 5.61b / Enterprise Value 92.99b)
FCF Margin = 21.79% (FCF TTM 5.61b / Revenue TTM 25.74b)
Net Margin = 8.54% (Net Income TTM 2.20b / Revenue TTM 25.74b)
Gross Margin = 26.98% ((Revenue TTM 25.74b - Cost of Revenue TTM 18.80b) / Revenue TTM)
Gross Margin QoQ = 18.05% (prev 29.93%)
Tobins Q-Ratio = 1.60 (Enterprise Value 92.99b / Total Assets 58.17b)
Interest Expense / Debt = 0.96% (Interest Expense 110.0m / Debt 11.50b)
Taxrate = 26.37% (202.0m / 766.0m)
NOPAT = 4.80b (EBIT 6.51b * (1 - 26.37%))
Current Ratio = 2.29 (Total Current Assets 13.79b / Total Current Liabilities 6.02b)
Debt / Equity = 0.61 (Debt 11.50b / totalStockholderEquity, last quarter 18.90b)
Debt / EBITDA = 0.93 (Net Debt 8.15b / EBITDA 8.76b)
Debt / FCF = 1.45 (Net Debt 8.15b / FCF TTM 5.61b)
Total Stockholder Equity = 18.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 2.20b / Total Assets 58.17b)
RoE = 11.97% (Net Income TTM 2.20b / Total Stockholder Equity 18.37b)
RoCE = 23.02% (EBIT 6.51b / Capital Employed (Equity 18.37b + L.T.Debt 9.92b))
RoIC = 17.31% (NOPAT 4.80b / Invested Capital 27.70b)
WACC = 10.07% (E(85.31b)/V(96.81b) * Re(11.33%) + D(11.50b)/V(96.81b) * Rd(0.96%) * (1-Tc(0.26)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF] Terminal Value 74.85% ; FCFF base≈4.31b ; Y1≈5.31b ; Y5≈9.05b
[DCF] Fair Price = 69.08 (EV 107.43b - Net Debt 8.15b = Equity 99.28b / Shares 1.44b; r=10.07% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -44.58 | EPS CAGR: -30.06% | SUE: -0.82 | # QB: 0
Revenue Correlation: 38.24 | Revenue CAGR: -3.21% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.090 | Chg30d=+0.100 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=+0.208 | Chg30d=+0.354 | Revisions Net=+6 | Growth EPS=+69.1% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=3.58 | Chg7d=+0.091 | Chg30d=+0.275 | Revisions Net=+5 | Growth EPS=+19.5% | Growth Revenue=+16.5%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.8% (Discount Rate 11.3% - Earnings Yield 2.6%)
[Growth] Growth Spread = -22.3% (Analyst -13.5% - Implied 8.8%)